PHARMA SANTE ENERGIE : revenue, balance sheet and financial ratios

PHARMA SANTE ENERGIE is a French company founded 33 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in POINTE-A-PITRE (97110), this company of category PME shows in 2018 a revenue of -19 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMA SANTE ENERGIE (SIREN 390248508)
Indicator 2019 2018 2017
Revenue N/C -19 276 € 94 237 €
Net income -1 090 € 442 769 € 6 648 €
EBITDA -3 833 € -39 527 € 65 444 €
Net margin N/C -2297.0% 7.1%

Revenue and income statement

In 2019, PHARMA SANTE ENERGIE records a net loss of 1 k€. This deficit will reduce equity on the balance sheet.

EBITDA (2019) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-3 833 €

EBIT (2019) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-3 833 €

Net income (2019) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-1 090 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 92%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2019) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2019) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

91.634%

Repayment capacity (2019) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Solvency indicators evolution
PHARMA SANTE ENERGIE

Sector positioning

Debt ratio
0.0 2019
2017
2018
2019
Q1: 35.68
Med: 104.11
Q3: 243.61
Excellent

In 2019, the debt ratio of PHARMA SANTE ENERGIE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
91.63% 2019
2017
2018
2019
Q1: 22.98%
Med: 40.68%
Q3: 60.84%
Excellent

In 2019, the financial autonomy of PHARMA SANTE ENERGIE (91.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2019
2017
2018
2019
Q1: 1.73 years
Med: 5.0 years
Q3: 9.48 years
Excellent

In 2019, the repayment capacity of PHARMA SANTE ENERGIE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1195.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2019) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1195.319

Interest coverage (2019) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-26.611

Liquidity indicators evolution
PHARMA SANTE ENERGIE

Sector positioning

Liquidity ratio
1195.32 2019
2017
2018
2019
Q1: 119.99
Med: 167.03
Q3: 236.26
Excellent

In 2019, the liquidity ratio of PHARMA SANTE ENERGIE (1195.32) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-26.61x 2019
2017
2018
2019
Q1: 1.36x
Med: 5.41x
Q3: 11.35x
Watch -26 pts over 3 years

In 2019, the interest coverage of PHARMA SANTE ENERGIE (-26.6x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 408 days. Excellent situation: suppliers finance 408 days of the operating cycle (retail model).

Operating WCR (2019) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2019) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2019) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

408 j

Inventory turnover (2019) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMA SANTE ENERGIE

Positioning of PHARMA SANTE ENERGIE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMA SANTE ENERGIE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMA SANTE ENERGIE

What is the revenue of PHARMA SANTE ENERGIE ?

The revenue of PHARMA SANTE ENERGIE in 2018 is -19 k€.

Is PHARMA SANTE ENERGIE profitable?

PHARMA SANTE ENERGIE recorded a net loss in 2019.

Where is the headquarters of PHARMA SANTE ENERGIE ?

The headquarters of PHARMA SANTE ENERGIE is located in POINTE-A-PITRE (97110), in the department Guadeloupe.

Where to find the tax return of PHARMA SANTE ENERGIE ?

The tax return of PHARMA SANTE ENERGIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMA SANTE ENERGIE operate?

PHARMA SANTE ENERGIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.